Skip to main content

Table 4 Patients’ quality of life and health status

From: Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133+ cells in ischemic refractory cardiomyopathy trial (RECARDIO)

Parameter

Baseline

6 months

12 months

p value

SF-12

 PCS

38.4 ± 4.6

44.0 ± 6.7

44.4 ± 6.0*

0.02

 MCS

49.8 ± 9.9

49.5 ± 13.2

49.2 ± 15.2

0.99

MLHFQ

35.9 ± 12.2

27.1 ± 10.7

33.1 ± 18.6

0.29

  1. Data presented as mean ± standard deviation
  2. SF-12, Short Form-12, PCS Physical Component Summary, MCS Mental Component Summary, MLHFQ Minnesota Living with Heart Failure Questionnaire
  3. *p ≤ 0.05 vs baseline